hERG Screening Market Growth Outlook: Proarrhythmia Risk...

aggiunto articolo blog Altre informazioni

2026-03-06 08:42:37 -

hERG Screening Market Growth Outlook: Proarrhythmia Risk Assessment, CRO Outsourcing Expansion, and Data Standardization Needs (2026–2034)

The hERG screening market is a specialized but mission-critical segment of preclinical drug safety—focused on identifying compounds that may disrupt cardiac repolarization and increase the risk of QT prolongation and drug-induced arrhythmias. hERG (human Ether-à-go-go-Related Gene) encodes a key potassium channel involved in the cardiac action potential, and unintended inhibition...

0 Commenti 0 Condivisioni 26 Visualizzazioni